Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AnaptysBio, Inc. ANAB

Set alert

Price alert · ANAB

All alert types
47.95 USD +1.04 +2.22%

As of Nov 3, 1:22 PM ET

Bid
47.93 × 2
Ask
48.00 × 2
47.36 Day range 48.35
20.18 52-week range 72.36
YTD
+48.36%
1 year
+99.54%
Open
47.36
Prev close
46.91
Mkt cap
1.43B
Vol
80.73K
Avg vol
484.03K
EPS
-0.96
P/E
0.00
Div yield
0.00%
More statistics
Low
47.36
High
48.35
Forward P/E
10.34
Beta
0.37
Short ratio
9.41
Inst. own
105.65%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
51.76
200-d avg
50.40
1y target
87.25

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 24, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 25, 2026Rating: TD Cowen · Buy → Buy
  • Sep 21, 2026Earnings: 5.11; estimate 5.11; surprise 0%
  • Sep 23, 2026Rating: Leerink Partners · Outperform → Outperform
  • Sep 24, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 30, 2026Rating: JP Morgan · Overweight → Overweight
  • Nov 3, 2026Earnings: —; estimate -1.84; surprise —%
Signals (17)
NameDateAgo
SMA: BearishOct 29, 20265 days ago
SMA: BullishOct 27, 20261 week ago
MACD: Buy SignalOct 15, 20262 weeks ago
RSI: OversoldOct 6, 20264 weeks ago
RSI: OversoldOct 1, 20261 month ago
SMA: BearishSep 9, 20261 month ago
SMA: BullishSep 3, 20262 months ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalAug 31, 20262 months ago
SMA: BearishAug 25, 20262 months ago
SMA: BullishAug 24, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BullishAug 11, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 87.25 +82.0% upside
Target (low)
60.00
Target (mean)
87.25
Target (high)
140.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ANAB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.530880.00 – 1.290.52+2.1%33.46M-56.2%3
Next quarter1.060.10 – 2.011.58-32.7%52.38M-51.6%3
Current year4.202.49 – 7.06-0.46+1012.5%101.12M-56.9%4
Next year4.542.42 – 8.774.20+8.1%171.31M+69.4%5

Upgrades and downgrades

The latest rating changes

ANAB analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026JP MorganMaintainedOverweightOverweight
Sep 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2026Leerink PartnersMaintainedOutperformOutperform
Aug 25, 2026TD CowenMaintainedBuyBuy
Aug 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 13, 2026UBSMaintainedBuyBuy
May 13, 2026BarclaysMaintainedOverweightOverweight
May 4, 2026Piper SandlerMaintainedOverweightOverweight
Apr 28, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 22, 2026BarclaysMaintainedOverweightOverweight
Apr 21, 2026UBSMaintainedBuyBuy
Mar 31, 2026Piper SandlerMaintainedOverweightOverweight
Mar 30, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 17, 2026UBSMaintainedBuyBuy
Mar 12, 2026WedbushMaintainedOutperformOutperform
Mar 9, 2026Truist SecuritiesMaintainedHoldHold
Mar 5, 2026StifelMaintainedBuyBuy
Mar 4, 2026BarclaysMaintainedOverweightOverweight
Mar 4, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 20, 2026BarclaysMaintainedOverweightOverweight
Dec 17, 2025BarclaysMaintainedOverweightOverweight
Dec 11, 2025StifelMaintainedBuyBuy
Nov 24, 2025WedbushReiteratedOutperformOutperform
Nov 24, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 11, 2025BarclaysMaintainedOverweightOverweight
Nov 11, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 10, 2025Truist SecuritiesMaintainedHoldHold
Nov 5, 2025GuggenheimMaintainedBuyBuy
Nov 5, 2025Wells FargoMaintainedOverweightOverweight
Oct 29, 2025StifelMaintainedBuyBuy